AXCELLA HEALTH INC (AXLA)

US05454B1052 - Common Stock

6.91  -1.03 (-12.97%)

Premarket: 6.7 -0.21 (-3.04%)

AXCELLA HEALTH INC

NASDAQ:AXLA (9/27/2023, 7:13:15 PM)

Premarket: 6.7 -0.21 (-3.04%)

6.91

-1.03 (-12.97%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)08-03 2023-08-03/bmo
Earnings (Next)10-30 2023-10-30/bmo
Ins Owners5.6%
Inst Owners1626.67%
Market Cap20.37M
Shares2.95M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.22
IPO05-09 2019-05-09
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AXLA Daily chart

Company Profile

Axcella Health, Inc. is a biotechnology company. The company is headquartered in Cambridge, Massachusetts and currently employs 11 full-time employees. The company went IPO on 2019-05-09. The firm is focused on a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). Its product candidates are comprised of multiple EMMs that are engineered in distinct combinations and ratios with simultaneously impacting multiple biological pathways. Its pipeline includes lead therapeutic candidates for the treatment of Long COVID (also known as Post-COVID-19 Condition and Post-Acute Sequelae of COVID-19 (PASC)) associated fatigue, and the treatment of non-alcoholic steatohepatitis (NASH). AXA1665 is a product candidate for the reduction in risk of Overt Hepatic Encephalopathy (OHE) recurrence in adult patients with liver cirrhosis. AXA1125 is also being developed as a product candidate for the treatment of Long COVID. AXA1125 is an oral product candidate for the treatment of NASH. AXA1125 is an oral product candidate that contains six amino acids and derivatives.

Company Info

AXCELLA HEALTH INC

840 Memorial Dr

Cambridge MASSACHUSETTS 02139

P: 16178680949.0

CEO: William R. Hinshaw

Employees: 11

Website: https://axcellatx.com/

AXLA News

News Image3 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

News Image8 days ago - ChartmillKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

News Image8 days ago - ChartmillThese stocks are moving in today's session

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

News Image8 days ago - InvestorPlaceBeware! 3 Biotech Stocks Waving Massive Red Flags Right Now

There are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of.

News Image9 days ago - ChartmillWhich stocks are experiencing notable movement on Tuesday?

Wondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

News Image9 days ago - ChartmillWhich stocks are moving on Tuesday?

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

AXLA Twits

Here you can normally see the latest stock twits on AXLA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example